Description

Haloperidol-Succinylglycyliodotyrosine is a specialized synthetic peptide derivative, primarily utilized as a key intermediate in advanced pharmaceutical research and development. This compound is of significant interest for its role in the synthesis of novel drug conjugates and targeted therapeutic agents, particularly within the field of neuropharmacology and oncology. It is essential for research institutions, pharmaceutical development laboratories, and fine chemical manufacturers focused on creating next-generation peptide-based pharmaceuticals and diagnostic tools.

Application

• Pharmaceutical Intermediate: Critical building block for the synthesis of advanced haloperidol-derived peptide conjugates and prodrugs.
• Research Chemical: Used in academic and industrial R&D for studying receptor binding, drug delivery mechanisms, and metabolic pathways.
• Targeted Therapy Development: Serves as a precursor in the design of ligand-targeted therapeutics for specific cell types or receptors.
• Radiopharmaceutical Precursor: Potential use in the development of iodine-123 or iodine-131 labeled compounds for diagnostic imaging or therapy.
• Peptide Library Synthesis: A valuable component in combinatorial chemistry for creating diverse peptide libraries for screening.
• Reference Standard: Employed as a high-purity analytical standard for quality control and method development in pharmaceutical analysis.

Basic Information

Product Name	Haloperidol-Succinylglycyliodotyrosine
CAS No.	113579-02-5
Molecular Formula	C34H41IN4O7
Molecular Weight	744.62 g/mol
Synonyms	Haloperidol Succinyl Glycyl Iodotyrosine; 4-(4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanone Succinyl-Glycyl-3-Iodotyrosine; Haldol Conjugate; Iodotyrosyl-Glycyl-Succinyl-Haloperidol; 3-Iodo-L-tyrosylglycyl-N6-(4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-oxobutyl)-L-lysine; Haloperidol Peptide Derivative; Neuroleptic Peptide Intermediate
EINECS	Contact for details

Quality Control

Our Haloperidol-Succinylglycyliodotyrosine is manufactured under strict quality control protocols to ensure high purity and batch-to-batch consistency, suitable for research and development applications. Each batch is accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We adhere to cGMP principles where applicable to support our clients' regulatory and quality assurance requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider desiccants or inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC/MS)	Conforms
Identification (IR)	Conforms to reference spectrum
Assay (HPLC)	≥ 95.0%
Purity (HPLC, Total)	≥ 98.0%
Water Content (KF)	≤ 2.0%
Residual Solvents (GC)	Meets ICH guidelines
Heavy Metals	< 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.